THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch
Huffstutter, J.E., Kafka, S., Brent, L.H., Matucci-Cerinic, M., Tang, K.L., Wang, J., Decktor, D.D., Chevrier, M., Sprabery, T., DeHoratius, R.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article